- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.12. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 05.12. | Prenetics Global Limited: Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services | 1 | GlobeNewswire (USA) | ||
| 27.11. | Prenetics Global Q3 Loss Narrows On Surge In Revenue | - | RTTNews | ||
| 27.11. | Prenetics Global: Q3 Earnings Insights | 1 | Benzinga.com | ||
| 27.11. | Prenetics Global Limited: Prenetics Announces Third Quarter 2024 Financial Results | 291 | GlobeNewswire (Europe) | Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta's Early Cancer... ► Artikel lesen | |
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 27.11. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 18.11. | Prenetics Global Limited: Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health | 2 | GlobeNewswire (USA) | ||
| 15.10. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.10. | Prenetics Global GAAP EPS of -$1.58, revenue of $5.9M | 4 | Seeking Alpha | ||
| 07.10. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.10. | Prenetics Global Limited: Prenetics Announces Second Quarter 2024 Financial Results | 384 | GlobeNewswire (Europe) | Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024Enters U.S. Health Market in October with IM8, a New Health and Wellness BrandRe-affirms Revenue Target to Exceed US$33 million for FY... ► Artikel lesen | |
| 27.09. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.09. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.08. | Prenetics Global Limited: Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry | 1 | GlobeNewswire (USA) | ||
| 12.07. | Prenetics partners with David Beckham for new health brand | 1 | TechNode | ||
| 12.07. | US health sciences company Prenetics partners with David Beckham for new health brand | 1 | TechNode | ||
| 11.07. | Renowned Footballer David Beckham Invests In Small Health & Wellness Firm Prenetics | 1 | Benzinga.com | ||
| 11.07. | Prenetics Global Limited: Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham | 403 | GlobeNewswire (Europe) | Beckham becomes a strategic investor in PreneticsBeckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics... ► Artikel lesen | |
| 11.07. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SCILEX | 0,406 | -11,03 % | SCLX-Aktie erreicht 52-Wochen-Tief bei 0,46 US-Dollar | ||
| QUANTUM-SI | 1,295 | -1,14 % | Quantum-Si präsentiert ProteoVue-Software für Proteinforschung | ||
| RECURSION PHARMACEUTICALS | 7,270 | +4,01 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen | |
| TEMPUS AI | 34,650 | -0,74 % | Tempus AI (NASDAQ:TEM) Shares Down 5.7% Following Insider Selling | ||
| SUMMIT THERAPEUTICS | 18,940 | +1,45 % | Where Will Summit Therapeutics Be in 5 Years? | ||
| ADMA BIOLOGICS | 17,390 | -1,86 % | ADMA Biologics, Inc.: ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility | ||
| EDGEWISE THERAPEUTICS | 29,660 | -1,07 % | Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains | ||
| 180 LIFE SCIENCES | 2,740 | +46,52 % | 180 Life Sciences Corp. - S-1/A, General form for registration of securities | ||
| JANUX THERAPEUTICS | 56,13 | -1,09 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 36,810 | -1,50 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors... ► Artikel lesen | |
| ARS PHARMACEUTICALS | 11,450 | +2,23 % | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Announces neffy (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies | ||
| ARCUTIS BIOTHERAPEUTICS | 14,980 | +0,07 % | Arcutis Biotherapeutics, Inc.: Arcutis Submits ZORYVE (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis | ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability profile... ► Artikel lesen | |
| NUVALENT | 82,83 | -1,22 % | Nuvalent-CEO Porter James Richard verkauft Aktien im Wert von 2,34 Millionen US-Dollar | ||
| ARCELLX | 77,10 | +0,40 % | Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
| ALPHA TEKNOVA | 8,615 | +12,17 % | Alpha Teknova Stock Hits 52-Week High at $8.93 Amid Growth Surge |
PRENETICS GLOBAL LIMITED gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 5,800 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.
